ESMO 2024: Focus on Breast Cancer

View informative breast cancer content, featuring an interview led by Dr. Karine Tawagi of the Two Onc Docs at ESMO 2024, which took place September 13-17 in Barcelona, Spain.

Imaging Effective in the Early Detection of Metastatic Disease in Early-Stage Breast Cancer

Rob DillardESMO Congress 2024 | December 3, 2024

Imaging modalities show significant efficacy in identifying metastasis among asymptomatic early-stage breast cancer.

Exciting Advancements in Triple-Negative Breast Cancer

Karine Tawagi, MDESMO Congress 2024 | December 3, 2024

Drs. Karine Tawagi and Adam Brufsky discuss exciting advancements and therapies on the horizon in the space of TNBC.

Therapeutic Options in Metastatic Triple-Negative Breast Cancer

Karine Tawagi, MDESMO Congress 2024 | December 3, 2024

Dr. Adam Brufsky speaks with Dr. Adam Brufsky about the optimal therapeutic options to use in the TNBC patient population.

The Biggest Challenges in Metastatic Triple-Negative Breast Cancer

Karine Tawagi, MDESMO Congress 2024 | December 3, 2024

Drs. Karine Tawagi and Adam Brufsky discuss the biggest current challenges in the TNBC space.

A Deep Learning Model for Predicting Outcomes in TNBC

Rob DillardESMO Congress 2024 | December 3, 2024

A multimodal deep learning prediction model demonstrated notable prognostic and therapeutic predictive value in TNBC.

Assessing the Impact of Aging on the Genetic Landscape of Advanced Breast Cancer

Rob DillardESMO Congress 2024 | December 3, 2024

Advanced breast cancer in older patients is characterized by distinct molecular features.